RNOH joins major national genome study
The RNOH has joined the 100,000 Genomes Project. The Trust received the green light to start recruitment into this important national project earlier this month. The aim is to create a new genomic medicine service for the NHS and as such transforming the way people are cared for.
The project will provide an opportunity for patients to be offered a diagnosis where there wasn’t one before and, in time, will help to deliver more effective treatments.
The project will sequence 100,000 genomes from around 70,000 people, and the RNOH is recruiting patients for both the rare disease arm of the study as well as cancer. Since receiving the green light to recruit, the RNOH has recruited five cancer patients and one rare disease patient.
Professor Flanagan, Head of Department of Pathology at the UCL Cancer Institute and clinical lead for histopathology at the RNOH, stressed the importance of the project: '"The 100,000 genomes project will transform the care that patients receive in the NHS. This transformation project will allow the accelerated introduction of a more personalised treatment of disease."
If you would like to know more about the project you can find more information on the 100,000 Genomes Project website.